サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1373928

アルファエミッター市場：核種別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Alpha Emitter Market, By Type of Radionuclide, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 311 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.33円
アルファエミッター市場：核種別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

アルファエミッター市場規模は2022年に4億1,687万米ドルと評価され、2023年から2030年にかけてCAGR 12.6％で拡大。

治療には、特殊な抗炎症剤の投与や、肺内の空気の通り道を広げることを目的とした革新的な気管支拡張術が含まれます。その他の特典として、症状の重篤度を軽減し増悪を予防する上で重要な役割を果たす粘液クリアランスを促進する目的でデザインされた標的薬剤がしばしば患者に有効です。治療計画は、症状管理、再燃の予防、肺機能の最適化に主眼を置きながら、各患者の具体的な要件に合わせて綿密に作成されます。気管支喘息に対処するためのこの包括的なアプローチにより、罹患者は呼吸器系の健康を改善し、より充実した生活を送ることができるようになります。

アルファエミッター市場-市場力学

過小診断されがちな疾患に対する認識の高まりが市場需要を促進

医学的知識と診断ツールの進歩により、気管支拡張症に対する認識が高まっています。加えて、人口動態の高齢化と慢性呼吸器疾患の急増により、より効果的な治療法に対する需要が高まっています。このような認識の高まりと患者数の増加が、製薬会社や研究者を、革新的な医薬品の開発を含む、気管支拡張症治療のための先駆的な解決策への投資に駆り立てています。こうした取り組みの極めて重要な原動力となっているのは、気管支拡張症患者の生活の質を向上させ、再発する症状や感染症の負担を軽減させるという追求です。

アルファエミッター市場-主要インサイト

当社の調査アナリストの評価によると、世界のアルファエミッター産業は、2023年から2030年までの予測期間を通じて、約12.6％の年間成長率を見込んでいます。

アルファエミッター分野は、しばしば過小診断される状態の認識の高まりが主な要因となって、大幅な拡大が見込まれています。

放射性核種のカテゴリーでは、ラジウム（Ra-223）が2022年に最も大きな市場シェアを示すと予想されています。

用途別では、骨転移が2022年に放射性核種の中でトップの座を占める。

地域別では、北米が2022年の主要な収益源として浮上しました。

アルファエミッター市場-セグメンテーション分析：

アルファエミッターの世界市場は、放射性核種の種類、アプリケーション、エンドユーザー、地域を包括的にセグメンテーションしています。

放射性核種の種類を考慮すると、市場は6つの異なるカテゴリーに分かれる：ラジウム（Ra-223）、アクチニウム（Ac-225）、鉛（Pb-212）、アスタチン-211、ビスマス-213、その他です。注目すべきは、ラジウム（Ra-223）がこのセグメンテーションでリードしていることです。ラジウム223（Ra-223）は、標的アルファ粒子療法、特に転移性前立腺がんの治療におけるその有効性により、非常に人気の高い放射性核種として際立っています。近傍の健康な細胞を保護しながら、がん性骨組織を特異的に標的にするその顕著な能力は、骨に転移した進行性前立腺がん患者のQOLと生存率の向上に大きく貢献しています。

アルファエミッター市場-地理的洞察

地理的な観点から、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカなど幅広い地域を網羅しています。これらの地域はさらに個々の国に細分化され、それぞれがビジネス展望に貢献しています。

北米は、がん治療と核医学におけるアルファ線放出装置の重要な役割から、アルファ線放出装置の重要な拠点として際立っています。標的を絞ったアルファ粒子放射におけるアルファ放出同位元素の利用は、がん治療への革新的なアプローチであり、さまざまな種類のがんに対処できる大きな可能性を秘めています。

アルファエミッター市場-競合情勢：

アルファエミッターの分野では、核医学と放射性医薬品を専門とする数多くの著名な企業の存在によって、競合情勢が特徴付けられます。Actinium Pharmaceuticals社、Curium社、Lantheus Holdings社など、業界をリードする企業は、医療用途のアルファ線放出同位元素の探索と生産において積極的な役割を果たしています。さらに、新興企業や研究機関がアルファ線放出核種を利用した独創的な医薬品や診断ツールの開発に積極的に貢献していることも、競合の背景に影響を与えています。

目次

第1章 アルファエミッタ市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 アルファエミッタの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 アルファエミッタ業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 アルファエミッター市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 アルファエミッター市場情勢

  • アルファエミッタ市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 アルファ放射体市場- 放射性核種の種類別

  • 概要
    • 放射性核種別のセグメントシェア分析
    • ラジウム（Ra-223）
    • アクチニウム（Ac-225）
    • 鉛（Pb-212）
    • アスタチン-211
    • ビスマス-213
    • その他

第8章 アルファエミッタ市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • 骨転移
    • 前立腺がん
    • 神経内分泌腫瘍
    • 卵巣がん
    • その他

第9章 アルファエミッタ市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院
    • 専門クリニック
    • 診断センター
    • その他

第10章 アルファエミッタ市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- アルファエミッター業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Actinium Pharmaceutical Inc.
    • Alpha Tau Medical Ltd
    • Bayer AG
    • Bracco
    • Cardinal Health
    • Eckert &Ziegle
    • Fusion Pharmaceuticals
    • IBA Worldwide
    • NorthStar Medical Radioisotopes（NMR）
    • Orano Group
    • Viewpoint Molecular Targeting
    • RadioMedix
    • Telix Pharmaceuticals Limited.
    • TerraPower, LLC
    • NIOWAVE Inc.
    • IONETIX Corporation.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Applications
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Alpha Emitter Market: Type of Radionuclide Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type of Radionuclide
  • TABLE Global Alpha Emitter Market, by Type of Radionuclide 2018-2030 (USD Million)
  • TABLE Alpha Emitter Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Alpha Emitter Market, by Application 2018-2030 (USD Million)
  • TABLE Alpha Emitter Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Alpha Emitter Market, by End User 2018-2030 (USD Million)
  • TABLE Alpha Emitter Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Alpha Emitter Market, by Region 2018-2030 (USD Million)
  • TABLE North America Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE North America Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Alpha Emitter Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE Europe Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Alpha Emitter Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE Asia Pacific Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Alpha Emitter Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE Latin America Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Alpha Emitter Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Alpha Emitter Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Alpha Emitter Market, by Type of Radionuclide, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Alpha Emitter Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Alpha Emitter Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Alpha Emitter Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type of Radionuclide segment market share analysis, 2022 & 2030
  • FIGURE Type of Radionuclide segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Alpha Emitter Market share and leading players, 2022
  • FIGURE Europe Alpha Emitter Market share and leading players, 2022
  • FIGURE Asia Pacific Alpha Emitter Market share and leading players, 2022
  • FIGURE Latin America Alpha Emitter Market share and leading players, 2022
  • FIGURE Middle East and Africa Alpha Emitter Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Alpha Emitter Market share analysis by country, 2022
  • FIGURE Germany Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Alpha Emitter Market share analysis by country, 2022
  • FIGURE India Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Alpha Emitter Market share analysis by country, 2022
  • FIGURE Brazil Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Alpha Emitter Market share analysis by country, 2022
  • FIGURE Saudi Arabia Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Alpha Emitter Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1806

REPORT HIGHLIGHT

Alpha Emitter Market size was valued at USD 416.87 Million in 2022, expanding at a CAGR of 12.6% from 2023 to 2030.

Alpha emitter medicines have proven effective in addressing the challenges of a rare autoimmune disorder known as "Bronchial Blaze." This condition is characterized by the abnormal inflammation and constriction of the bronchial tubes, which can result in debilitating symptoms such as persistent breathlessness, chronic coughing, and frequent pulmonary flare-ups. The treatment regimen for Bronchial Blaze involves a multifaceted approach tailored to the individual needs of each patient. This approach prioritizes alleviating symptoms, minimizing the risk of recurring episodes, and enhancing overall lung function to enhance the quality of life for those afflicted by this condition.

Therapies may include the administration of specialized anti-inflammatory agents, as well as innovative bronchodilation techniques aimed at expanding the air passages within the lungs. Additionally, patients often benefit from targeted medications designed to promote mucus clearance, which plays a crucial role in reducing the severity of symptoms and preventing exacerbations. The treatment plan is meticulously crafted to cater to each patient's specific requirements, with a primary focus on symptom management, prevention of flare-ups, and the optimization of lung function. This comprehensive approach to addressing Bronchial Blaze ensures that affected individuals can lead more fulfilling lives with improved respiratory health.

Alpha Emitter Market- Market Dynamics

Rising awareness of this often-underdiagnosed condition propel market demand

With advancements in medical knowledge and diagnostic tools, there is a growing recognition of bronchiectasis cases. Additionally, an aging demographic and the surge in chronic respiratory conditions have amplified the demand for more effective treatments. This heightened awareness and the expanding patient population have spurred pharmaceutical companies and researchers to invest in pioneering solutions for bronchiectasis care, including the development of innovative pharmaceuticals. A pivotal driving force behind these efforts is the quest to enhance the quality of life for bronchiectasis patients, lessening the burden of recurrent symptoms and infections.

Alpha Emitter Market- Key Insights

According to our research analyst's assessment, the global Alpha Emitter industry anticipates an annual growth rate of approximately 12.6% throughout the forecast period spanning from 2023 to 2030.

The Alpha Emitter sector is poised for substantial expansion, largely driven by the increasing recognition of a condition that often goes underdiagnosed.

Within the Radionuclide category, Radium (Ra-223) is expected to exhibit the most significant market share in the year 2022.

In terms of application breakdown, Bone Metastases claimed the top position among Radionuclide types in 2022.

Geographically, North America emerged as the primary source of revenue generation in the year 2022.

Alpha Emitter Market- Segmentation Analysis:

The Global Alpha Emitter Market exhibits a comprehensive segmentation, which encompasses Type of Radionuclide, Application, End User, and Region.

When considering the Type of Radionuclide, the market branches into six distinct categories: Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, and Others. Notably, Radium (Ra-223) takes the lead in this segmentation. Radium-223 (Ra-223) stands out as a highly sought-after radionuclide due to its effectiveness in targeted alpha-particle therapy, particularly in the treatment of metastatic prostate cancer. Its remarkable ability to specifically target cancerous bone tissue while safeguarding healthy cells in the vicinity contributes significantly to improving the quality of life and survival rates for patients dealing with advanced prostate cancer that has spread to the bones.

Alpha Emitter Market- Geographical Insights

From a geographical perspective, this market encompasses a wide range of regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further subdivided into individual countries, each contributing to the business landscape.

North America stands out as a significant hub for Alpha emitters due to their crucial role in cancer therapy and nuclear medicine. The utilization of alpha-emitting isotopes in targeted alpha-particle radiation represents an innovative approach to cancer treatment, holding great potential for addressing a variety of cancer types.

Alpha Emitter Market- Competitive Landscape:

The arena of alpha emitters presents a competitive landscape marked by the presence of numerous prominent companies specializing in nuclear medicine and radiopharmaceuticals. Established industry leaders such as Actinium Pharmaceuticals, Curium, and Lantheus Holdings play active roles in the exploration and production of alpha-emitting isotopes for medical applications. Furthermore, the competitive backdrop is influenced by the contributions of startups and research institutions, as they actively contribute to the development of inventive pharmaceuticals and diagnostic tools based on alpha emitters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALPHA EMITTER MARKET KEY PLAYERS

  • Actinium Pharmaceutical Inc.
  • Alpha Tau Medical Ltd
  • Bayer AG
  • Bracco
  • Cardinal Health
  • Eckert & Ziegle
  • Fusion Pharmaceuticals
  • IBA Worldwide
  • NorthStar Medical Radioisotopes (NMR)
  • Orano Group
  • Viewpoint Molecular Targeting
  • RadioMedix
  • Telix Pharmaceuticals Limited.
  • TerraPower, LLC
  • NIOWAVE Inc.
  • IONETIX Corporation

GLOBAL ALPHA EMITTER MARKET, BY TYPE OF RADIONUCLIDE

  • Radium (Ra-223)
  • Actinium (Ac-225)
  • Lead (Pb-212)
  • Astatine-211
  • Bismuth-213
  • Others

GLOBAL ALPHA EMITTER MARKET, BY APPLICATION

  • Bone Metastases
  • Prostate Cancer
  • Neuroendocrine Tumors
  • Ovarian Cancer
  • Others

GLOBAL ALPHA EMITTER MARKET, BY END USER

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others

GLOBAL ALPHA EMITTER MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Alpha Emitter Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Alpha Emitter Market Snippet by Type of Radionuclide
    • 2.1.2. Alpha Emitter Market Snippet by Application
    • 2.1.3. Alpha Emitter Market Snippet by End User
    • 2.1.4. Alpha Emitter Market Snippet by Country
    • 2.1.5. Alpha Emitter Market Snippet by Region
  • 2.2. Competitive Insights

3. Alpha Emitter Key Market Trends

  • 3.1. Alpha Emitter Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Alpha Emitter Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Alpha Emitter Market Opportunities
  • 3.4. Alpha Emitter Market Future Trends

4. Alpha Emitter Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Alpha Emitter Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Alpha Emitter Market Landscape

  • 6.1. Alpha Emitter Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Alpha Emitter Market - By Type of Radionuclide

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type of Radionuclide, 2022 & 2030 (%)
    • 7.1.2. Radium (Ra-223)
    • 7.1.3. Actinium (Ac-225)
    • 7.1.4. Lead (Pb-212)
    • 7.1.5. Astatine-211
    • 7.1.6. Bismuth-213
    • 7.1.7. Others

8. Alpha Emitter Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Bone Metastases
    • 8.1.3. Prostate Cancer
    • 8.1.4. Neuroendocrine Tumors
    • 8.1.5. Ovarian Cancer
    • 8.1.6. Others

9. Alpha Emitter Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty Clinics
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Others

10. Alpha Emitter Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Alpha Emitter Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Alpha Emitter Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Alpha Emitter Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Alpha Emitter Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Alpha Emitter Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Alpha Emitter Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Actinium Pharmaceutical Inc.
    • 11.2.2. Alpha Tau Medical Ltd
    • 11.2.3. Bayer AG
    • 11.2.4. Bracco
    • 11.2.5. Cardinal Health
    • 11.2.6. Eckert & Ziegle
    • 11.2.7. Fusion Pharmaceuticals
    • 11.2.8. IBA Worldwide
    • 11.2.9. NorthStar Medical Radioisotopes (NMR)
    • 11.2.10. Orano Group
    • 11.2.11. Viewpoint Molecular Targeting
    • 11.2.12. RadioMedix
    • 11.2.13. Telix Pharmaceuticals Limited.
    • 11.2.14. TerraPower, LLC
    • 11.2.15. NIOWAVE Inc.
    • 11.2.16. IONETIX Corporation.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us